Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) — Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on […]
Micron Technology to Report Fiscal First Quarter Results on December 18, 2018
BOISE, Idaho, Nov. 19, 2018 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced that it will hold its […]
K2M Group Holdings, Inc. Announces Fundamental Change With Respect to its 3.00% Convertible Senior Notes due 2025 and 4.125% Convertible Senior Notes due 2036
LEESBURG, Va., Nov. 19, 2018 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (“K2M”) today announced that, in connection with the […]
Finisar to Release Second Quarter 2019 Financial Results on December 3
SUNNYVALE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) — Finisar Corporation (NASDAQ: FNSR), a global technology leader in high-speed optical communications, […]
Five Below, Inc. Announces Third Quarter Fiscal 2018 Earnings Conference Call
PHILADELPHIA, PA, Nov. 19, 2018 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens […]
Nuance Announces Plan to Spin Off Its Automotive Segment to Shareholders as a Separate Public Company
BURLINGTON, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) — Nuance Communications, Inc. (NASDAQ: NUAN) today announced its intention to spin off […]
TSX News -
White Rose Update
CALGARY, Alberta, Nov. 19, 2018 (GLOBE NEWSWIRE) — Operations remain suspended at the SeaRose floating production, storage and offloading (FPSO) […]
Nuance Announces Fourth Quarter and Fiscal Year 2018 Results
Exceeded Non-GAAP Revenue, EPS, Cash Flow and Margin Expectations Announced Strategic Actions after Comprehensive Portfolio Reviews Implemented Significant Changes to […]
Wright Medical Group N.V. to Present at BMO Prescriptions for Success Healthcare Conference
Wednesday, December 12, 2018 at 8:40 a.m. Eastern Time AMSTERDAM, The Netherlands, Nov. 19, 2018 (GLOBE NEWSWIRE) — Wright Medical […]
TSX News -
BELLUS Health Announces Positive Top-Line Phase 1 Results for its Chronic Cough Drug Candidate BLU-5937
– No Taste Loss at the Anticipated Therapeutic Doses – – BLU-5937 is Shown to be Safe and Well Tolerated […]
